Co-localized Substance Use and Hepatitis C Treatment

Simple item page
dc.contributor.authorLee, Andrewen
dc.contributor.authorTarasidis, Charlesen
dc.contributor.authorVenuto-Ashton, Angela D.en
dc.contributor.authorRubio, Marrieth G.en
dc.date.accessioned2023-03-14T18:19:58Zen
dc.date.available2023-03-14T18:19:58Zen
dc.date.issued2022-10-24en
dc.date.updated2023-03-14T18:13:09Zen
dc.description.abstractIn the US, there has been a dramatic rise in hepatitis C infection and a shifting demographic with the highest rates in persons aged 20-39 years. Injection drug use is the most common mode of transmission. While many novel strategies to expanding hepatitis C treatment have been proposed, there has been little reported progress toward establishing a standardized, wide scale approach. In response, we developed a pilot quality improvement program combining screening and initiation of hepatitis C treatment utilizing a simplified algorithm adapted for the office based opioid treatment (OBOT) to provide co-localization of substance use and hepatitis C treatment. Initial results revealed a high rate of seroprevalence among screened OBOT patients highlighting several challenges faced by this population including lack of awareness of infection and barriers to accessing care. Within this same group, 48.2% had either initiated or completed their course of DAA treatment within the first 6 months of the intervention phase of the program. Targeting patients in outpatient substance use treatment could identify a subset of at risk individuals with a high propensity for engaging and facilitate following through with hepatitis C treatment. On site treatment is an efficient alternative for treatment.en
dc.format.mimetypeapplication/pdfen
dc.identifier.urihttp://hdl.handle.net/10919/114104en
dc.language.isoenen
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjectHepatitis C treatmenten
dc.subjectSubstance abuseen
dc.titleCo-localized Substance Use and Hepatitis C Treatmenten
dc.typeConference proceedingen
dc.typePosteren
dc.type.dcmitypeTexten
pubs.finish-date2022-10-26en
pubs.organisational-group/Virginia Techen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicineen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/Internal Medicineen
pubs.organisational-group/Virginia Tech/VT Carilion School of Medicine/Internal Medicine/Hospital Medicineen
pubs.start-date2022-10-24en

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
PDF Co-Localized Substance Use and Hepatitis C Treatment.pdf
Size:
263.14 KB
Format:
Adobe Portable Document Format
Description:
Poster
Download

Collections

All Faculty Deposits
Scholarly Works, Virginia Tech Carilion School of Medicine (VTCSOM)